Research/Academic Interests

Dr. Bloch’s research is focused on innovative new therapies for the treatment of primary and metastatic cancers of the brain. His laboratory studies mechanisms of immune resistance in patients with cancer to identify new targets to enhance the immune response to tumors. Additionally, Dr. Bloch’s Brain Tumor Immunotherapy Laboratory provides immune monitoring and biomarker development for pre-clinical and clinical trials of immunotherapy for glioblastoma, the most common and malignant type of brain tumor. The laboratory has been continuously funded by NIH since 2013 and has produced numerous trainees who are now in practice around the United States advancing the care of brain tumor patients.

Dr. Bloch is also highly involved in clinical research and clinical trials to improve outcomes for his patients. His current studies are focused on the use of vaccine therapies for glioblastoma, viral therapies for glioblastoma, immune checkpoint modulation for glioblastoma and brain metastases, laser ablation therapy combined with immunotherapy, and stereotactic radiosurgery combined with immunotherapy.